(Q37161958)

18 August 2017

Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis (English)

1 reference

18 August 2017

0 references

1 reference

1 reference

K E Corey

1

1 reference

18 August 2017

J Mendez-Navarro

2

1 reference

18 August 2017

E C Gorospe

3

1 reference

18 August 2017

H Zheng

4

1 reference

18 August 2017

R T Chung

5

1 reference

18 August 2017

6 August 2009

1 reference

18 August 2017

7

1 reference

Journal of Viral Hepatitis

inferred from page(s)

published in

1 reference

18 August 2017

17

1 reference

18 August 2017

3

1 reference

18 August 2017

201-207

1 reference

Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon alpha.

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

Twelve-week treatment of acute hepatitis C virus with pegylated interferon- alpha -2b in injection drug users

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

Outcomes and Treatment of Acute Hepatitis C Virus Infection in a United States Population

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

Acute hepatitis C virus infection

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

A short course of pegylated interferon-alpha in acute HCV hepatitis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

Viral clearance or persistence after acute hepatitis C infection: interim results from a prospective study.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

Acute hepatitis C in patients receiving hemodialysis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

Clinical course and outcome of a nosocomial outbreak of hepatitis C in a urology ward

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

Duration of peginterferon therapy in acute hepatitis C: a randomized trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

Pegylated interferon alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

Natural course of acute hepatitis C: a long-term prospective study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

Treatment of acute hepatitis C with interferon alfa-2b

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

Hepatitis C viral genotype influences the clinical outcome of patients with acute posttransfusion hepatitis C.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

A randomized controlled trial of recombinant interferon alpha-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769693

Resolution of acute hepatitis C after therapy with natural beta interferon

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19674285

12 December 2020

inferred from PubMed ID database lookup

Barriers to interferon-alpha therapy are higher in intravenous drug users than in other patients with acute hepatitis C

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19674285

12 December 2020

inferred from PubMed ID database lookup

Peginterferon Alfa-2b Therapy in Acute Hepatitis C: Impact of Onset of Therapy on Sustained Virologic Response

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19674285

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1111/J.1365-2893.2009.01167.X

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hnazoenclfdqjacn42qqhg7i4y

30 July 2022

release_hnazoenclfdqjacn42qqhg7i4y

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hnazoenclfdqjacn42qqhg7i4y

30 July 2022

https://api.fatcat.wiki/v0/release/hnazoenclfdqjacn42qqhg7i4y

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/hnazoenclfdqjacn42qqhg7i4y

PubMed publication ID

1 reference

30 July 2022